These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3936030)

  • 41. [Effect of intracisternal 6-hydroxydopamine on the cardiovascular response induced by carotid occlusion and asphyxia in rats].
    Romero Vecchione E; Saturno N; Augusto Campos H
    Acta Cient Venez; 1987; 38(1):67-72. PubMed ID: 3122481
    [No Abstract]   [Full Text] [Related]  

  • 42. Changed sensitivity of alpha 2-adrenoceptors mediating a decrease in protein kinase inhibitor activity in the brain of vasopressin-hypertensive rats.
    Szmigielski A; Szadowska A; Szmigielska H; Starke K
    Eur J Pharmacol; 1986 Mar; 122(1):1-10. PubMed ID: 3007171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect on brain 5-HT of central lysine-vasopressin administration into different cerebral ventricular compartments depends on the site of injection.
    Günther O; Szabó G; Kovács GL; Telegdy G
    Neuropeptides; 1986 Apr; 7(3):241-5. PubMed ID: 3713994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Central 6-hydroxydopamine and renal sodium retention in mineralocorticoid-treated rats.
    Hall JL; Mecca TE; Malvin RL; Webb RC
    Can J Physiol Pharmacol; 1986 Dec; 64(12):1572-5. PubMed ID: 3103902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antihypertensive effects of drugs measured in unanesthetized rats with established adrenal regeneration hypertension.
    Stanton HC; Cooper CM
    Arch Int Pharmacodyn Ther; 1967 Jul; 168(1):1-13. PubMed ID: 6048726
    [No Abstract]   [Full Text] [Related]  

  • 46. Neurogenic hypertension after depletion of norepinephrine in anterior hypothalamus induced by 6-hydroxydopamine administration into the ventral pons: role of serotonin.
    Benarroch EE; Balda MS; Finkielman S; Nahmod VE
    Neuropharmacology; 1983 Jan; 22(1):29-34. PubMed ID: 6405300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of intracerebroventricular injection of 5,6-dihydroxytryptamine and 6-hydroxydopamine on supra-ependymal nerves.
    Lorez HP; Richards JG
    Brain Res; 1976 Oct; 116(1):165-71. PubMed ID: 974766
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of various hypotensive agents on locomotor activity and blood pressure of rats.
    Singh PP; Junnarkar AY; Varma RK; Thomas GP; Tripathi RM
    Mater Med Pol; 1990; 22(3):176-8. PubMed ID: 2132423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of norepinephrine depletion on cerebral blood flow in the rat.
    Onesti ST; Strauss RC; Mayol B; Solomon RA
    Brain Res; 1989 Jan; 477(1-2):378-81. PubMed ID: 2495151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies of the hypotensive effect of calcium injected into lateral brain ventricles.
    Borowitz JL; Stebbins G; Isom GE; Johnson GE
    Res Commun Chem Pathol Pharmacol; 1987 Jan; 55(1):67-74. PubMed ID: 3563107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of norepinephrine on aortic 42K turnover during deoxycorticosterone acetate hypertension and antihypertensive therapy in the rat.
    Jones AW; Sander PD; Kampschmidt DL
    Circ Res; 1977 Aug; 41(2):256-60. PubMed ID: 872301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes of prostaglandin synthesis in aorta, brain and kidney medulla of normal rats treated with antihypertensive drugs.
    Taube C; Hauser A; Dunemann A; Förster W
    Acta Biol Med Ger; 1978; 37(5-6):889-90. PubMed ID: 742309
    [No Abstract]   [Full Text] [Related]  

  • 53. New evidence for neuronal function of vasopressin: sympathetic mediation of intrathecal vasopressin-induced hypertension.
    Tan DP; Tsou K
    Peptides; 1986; 7(4):569-72. PubMed ID: 3763434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Participation of central norepinephrine in the development of two-kidney, one clip Goldblatt hypertension.
    Nakada T; Koike H; Katayama T
    J Urol; 1986 May; 135(5):1066-70. PubMed ID: 3083123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Central adrenergic neurones and the initiation and development of experimental hypertension.
    Haeusler G; Finch L; Thoenen H
    Experientia; 1972 Oct; 28(10):1200-3. PubMed ID: 5087039
    [No Abstract]   [Full Text] [Related]  

  • 56. Habituation failure of skin conductance response after intraventricular administration of 6-hydroxydopamine in cats.
    Yamamoto K; Hagino K; Moroji T; Ishii T
    Experientia; 1984 Apr; 40(4):344-5. PubMed ID: 6425074
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The influence of premedication with 6-OH-dopamine and long-term administration of thymoanaleptics on development of experimental arterial hypertension.
    Bobkiewicz T; Chodera A; Godlewski J; Nowakowska E
    Arch Immunol Ther Exp (Warsz); 1976; 24(4):491-5. PubMed ID: 999465
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New drugs in hypertension.
    Myers MG
    Can Med Assoc J; 1977 Jan; 116(2):173-6. PubMed ID: 343894
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of intracerebroventricularly and intracisternally administered vasopressin on the hypothalamic self-stimulation rate of the rat.
    Günther O; Schwarzberg H
    Neuropeptides; 1987; 10(4):361-7. PubMed ID: 3431670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increase of the peroxidase activity of mouse submaxillary gland by reserpine.
    Chakraborty R; Mukherjee B; Hati RN
    Life Sci; 1984 Nov; 35(19):1913-9. PubMed ID: 6436608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.